Highlights for the Quarter
• Two APAS® Independence instruments sold in the UK to Health Services Laboratory
• US multi-laboratory purchasing opportunities - AdventHealth and Vizient
• EU Urine analysis modules released as evaluation modules ahead of regulatory clearance
• First published data demonstrating use of APAS® Independence for early culture plate reading
• Joanne Moss appointed as Chair-Elect as part of planned Board rejuvenation
• 30 June 2021 cash balance of $9.6 million
For more information, download the attached PDF.
Download this document
